Several ActinomyceteslStreptomycetes expression vectors are described for expression of the Vitreoscilla haemoglobin gene (vhb) in an industrial erythromycin-producing strain of Saccharopolyspora erythraea. Cloning of vhb under the control of either the thiostrepton-inducible PtipA promoter or the constitutive Perm€* promoter led to the production of chemically active haemoglobin (VHb) in Streptomyces lividans TK24 transformed with these constructs. However, the plasmids could not be transformed into Sac. erythraea. Transformants of Sac. erythraea andlor exconjugants were obtained using a novel Escherichia colilStreptomyces shuttle vector comprised of vhb under the control of the Perm€* promoter, the Streptomyces plasmid plJ350 origin of replication, the thiostrepton-resistance gene (tsr) for selection, and the oriT region which is necessary for conjugal transfer. Increased plasmid stability in Sac. erythraea was obtained by construction of a vector for chromosomal integration. This vector contained the Streptomyces phage &31 attachment site for chromosomal integration and vhb expressed under the PmerR promoter and was stably maintained in the chromosome of Sac. erythraea. Shake-flask cultivations of the transformed Sac. erythraea strain with the chromosomally integrated vhb gene show that vhb is expressed in an active form. The corresponding amount of erythromycin produced in the vhbexpressing strain was approximately 60% higher relative t o the original VHbnegative strain.
INTRODUCTION
Erythromycin is a clinically important and potent macrolide antibiotic produced by the Gram-positive actinomycete Saccharopolyspora erythraea (Weber et al., 1985) . It is used to treat infections by several prokaryotic pathogens such as Streptococcus, Staph ylococcus, Mycoplasma, Ureaplasma, Chlamydia and Legionella (Nakayama, 1984) . The current annual production of erythromycin is more than 2 tonnes and the pharmaceutical demand for this antibiotic is increasing annually. Despite intensive efforts using classical strain development techniques and bioprocess optimization methods, maximum attainable final concentrations of erythromycin using Sac. erythraea are low in comparison to other industrially produced antibiotics such as penicillin or cephalosporin C. Since traditional methods have not greatly increased erythromycin production, our approach was to modify Sac. erythraea by metabolic engineering (Bailey, 1991) to improve its overall productivity. Special emphasis was placed on improving oxygen metabolism, as this might be a limiting factor for erythromycin synthesis in this organism.
Previous experiments using other industrially important organisms have shown that expression of a bacterial haemoglobin gene (vhb) originally isolated from Vitreoscilla sp. (Khosla & Bailey, 1988a) can significantly improve cell growth and productivity (Khosla & IP: 54.70.40.11 On: Thu, 03 Jan 2019 06:45:43 P. B R U N K E R a n d OTHERS Bailey, 1988b) . It was demonstrated that expression of vhb in Acremonium chrysogenum led to a threefold increase in cephalosporin C production (DeModena et al., 1993) . Furthermore, the yield of human tissue plasminogen activator (tPA) from Chinese hamster ovary cells (Pendse & Bailey, 1994) , L-lysine production of Corynebacterium glutamicum (Sander et al., 1994) , and total protein secretion, neutral protease activity and a-amylase activity of Bacillus subtilis (Kallio & Bailey, 1996) were all increased in the presence of active Vitreoscilla haemoglobin (VHb) in these organisms. Even in transgenic tobacco plants expressing vhb, a positive effect on an oxygen-dependent step in nicotine synthesis was observed which led to a 34% increase in nicotine content (Holmberg et al., 1997) . The recombinant tobacco plants also showed earlier germination and flowering and were able to produce plant material (dry weight) faster relative to the controls.
These examples of the beneficial effects of VHb in a variety of classes of organisms prompted us to clone and express the haemoglobin gene from Vitreoscilla sp. into Sac. erythraea.
In this work we describe for the first time the stable chromosomal integration of a vhb expression cassette into an industrial erythromycin-producing strain of Sac. erythraea and show that erythromycin production in the recombinant vhb-expressing strain was significantly enhanced compared to the original strain.
METHODS
Bacterial strains, plasmids and culture conditions. All bacterial strains and plasmids used are listed in Table 1 . Escherichia coli strains were grown at 37 "C in either 2 x YT or LB liquid medium (Sambrook et al., 1989) or on 2 x YT plates containing 1.6 '/ o (w/v) agar. Streptomyces lividans strains were maintained on R5 plates (Hopwood et al., 1985) or incubated in SM liquid medium (Birr et al., 1989) at 30 "C. Sac. erythraea was grown in the same media at 34 "C. S. lividans stocks were stored as spore solutions in 20% (v/v) glycerol at -20 "C, whereas mycelial stocks of Sac. erythraea were kept at -80 "C in 30% (v/v) glycerol. Media were supplemented with the appropriate antibiotics (100 pg ampicillin rnl-', 12.5 pg thiostrepton rnl-', 50 pg kanamycin rnl-', 30 pg chloramphenicol ml-', or 40 pg nalidixic acid ml-l) as needed.
Isolation and manipulation of DNA. Minipreparations of plasmid DNA were done by an alkaline lysis method as described by Lee & Rasheed (1990) . Genomic DNA from S. lividans and Sac. erythraea was isolated according to protocols by Hopwood et al. (1985) . Restriction enzymes, T 4 DNA ligase, alkaline phosphatase, Klenow polymerase and Pwo polymerase were obtained from commercial sources and used as recommended by the manufacturers. Standard DNA techniques and Southern blot analyses were performed as described by Sambrook et al. (1989) . PCR for amplification of PmerR and vhb was performed with a GeneAmp 9600 PCR system (Perkin Elmer) using template-specific conditions. All PCR fragments used for subsequent expression of vh6 were confirmed by DNA sequencing using the dideoxynucleotide chain-termination method (Sanger et al., 1977) .
Transformation of bacterial cells. Competent E. coli XL-1 Blue (Bullock et al., 1987) and ET12567 (MacNeil et al., 1992) were prepared and transformed by the method of McKenney et al. (1981) . Preparation of S. lividans protoplasts and PEGmediated transformation were performed according to the protocol of Hopwood et al. (1985) . For Sac. erythraea, this protocol was slightly modified. The cells were grown for 4-5 d in TSB (Oxoid) containing 0.25% (w/v) glycine. For protoplast formation, the final concentration of lysozyme was 8 mg ml-l (instead of 4 mg ml-l for S. lividans) and PEG-3350 (Sigma) was used instead of PEG-1000 in the transformation reaction. Furthermore, for transformation of Sac. erythraea, non-methylated DNA isolated from E. coli ET12567 was used. Since regeneration of Sac. erythraea protoplasts seemed to be much slower than that of S. lividans protoplasts, the antibiotic overlay was performed 48 h after transformation. Conjugational transfer of plasmids from E. coli to Sac. erythraea was performed on plates as described by Bierman et al. (1992) .
Detection of VH b and activity assays. vhb-expressing strains of S. lividans and Sac. erythraea were grown in 200 ml SM medium for 4-5 d at 30 "C and 34 "C, respectively, in a rotary shaker incubator at 250-300 r.p.m. Cells were harvested, washed twice in buffer (100 mM Tris/HCl pH 7.5, 50 mM NaC1, 1 mM EDTA), resuspended in 20ml buffer and disrupted by passing three times through a French press (Aminco SLM Instruments) operated at 1000-1500 p.s.i. (6.9-10.3 MPa). The soluble cellular fraction was used for Western blots (Winston et al., 1987) after separating the proteins by 15 ' / o SDS-PAGE and for determination of the COdifference spectrum (Webster & Liu, 1974) . The rabbit antiVHb serum was obtained from Cocalico Biologicals. The protein concentration in the samples was determined by the method of Bradford (1976) using Bio-Rad dye reagent and bovine serum albumin as the standard. Total protein concentration of samples from shake-flask cultivations was determined as described by Gerhardt et al. (1994) .
Shake-flask cultivations of Sac. erythraea. A seed culture of 30 ml vegetative medium I [per litre: 16 g Argo corn starch, 10 g dextrin, 15 g soybean flour, 2.5 g NaC1,5 ml corn-steep liquor, 1 g (NH,),SO,, 6 ml soybean oil and 4 g CaCO,, pH adjusted to 6-51 in 250 ml baffled shake flasks was inoculated with 1-5 ml glycerol stock and incubated for 40 h at 34 "C with 250 r.p.m. agitation [2 inch (5 cm) stroke] in a humidized rotary shaker incubator (Infors). Seed culture (3 ml) was inoculated into 27 ml half-strength fermentation medium I (Fl) [per litre: 35 g corn starch, 32 g dextrin, 33 g soybean flour, 7 g NaC1,20 ml corn-steep liquor, 2 g (NH,),SO,, 6 ml soybean oil and 8 g CaCO,? pH adjusted to 6.51. Cultivations for erythromycin production were run for 9 d with the following daily addition of soybean oil (0.2 ml, days 0-6) and n-propanol (0.1 ml, days 0-5 and 0.15 ml, days 6-9) starting at the day of inoculation of F1. The shake flasks were weighed daily and sterile water was added to compensate for evaporation if necessary.
Erythromycin bioassay. The titres of erythromycin produced by the industrial Sac. erythraea strain and its genetically engineered derivative were determined using a conventional bioassay with commercially available erythromycin (Fluka) as a standard. Portions (35 ml) of test medium [27*5 g TSB l-', 2 g glucose l-l, 2 % (w/v) agar] were poured into Petri dishes (12 x 12 cm). Once the medium was solidified, a second layer consisting of 35 ml test medium containing 35 p1 of a Micrococcus luteus overnight culture (grown 18 h at 30 "C in LB), was added. The erythromycin titre was determined by pipetting 10 p1 culture supernatant (or appropriate dilutions in Improved erythromycin production in Sac. erythraea Altenbuchner et al. (1992) methanol) on antibiotic test disks (6.6 mm diameter; Difco)
placed onto the solidified test plates. After 48 h incubation at 30 "C, the growth-inhibition zones of M. luteus were measured and the erythromycin titre (g 1-l) was calculated using a standard curve.
RESULTS

Expression of vhb in S. lividans
As no suitable expression vectors were available for Sac.
erythraea in the public domain, the vhb gene from Vitreoscilla sp. was first subcloned into S. Zividans expression plasmids. After the expression of active vhb in S. lividans TK24 was confirmed, Sac. erythraea could be transformed with these constructs.
The vhb gene was amplified by PCR using pRED2 (Khosla & Bailey, 1988a ) as a template. The primers for this PCR reaction were designed to generate BamHI sites at both the 5' and 3' ends of the gene. An additional NdeI site at the 5' end of the vhb gene was also introduced. The PCR fragment was ligated into the BamHI-digested vector pIC19H (Marsh et al., 1984) , resulting in the plasmid pETR352. After the nucleotide sequence of vhb was confirmed by DNA sequencing, the gene was cloned as a NdeIIBamHI or BamHI fragment into the Streptomyces expression vectors, PI 56021 and pIJ4090, respectively (Bibb & Janssen, 1986; Takano et al., 1995) , resulting in the plasmids pETR364 and pETR3.55 (Fig. la) . In pETR364, vhb is under the control of the thiostrepton-inducible PtipA promoter, whereas in pETR355, vhb expression occurs from the constitutive PermE':' promoter.
S. lividans TK24 cells containing either pETR364 or pETR355 were grown in 10 ml SM medium for 4 d to study vhb expression. In the case of S. lividans TK24 harbouring pETR364, thiostrepton (2-20 pg ml-l) was added after 3 d to induce the PtipA promoter. VHb synthesis was observed in both expression systems, as shown by Western blot analysis (Fig. lb) . Whilst the expression of vhb under the control of the PermE::-promoter was constitutive, as expected, the PtipA promoter required induction with thiostrepton : 5 pg ml-l thiostrepton was sufficient for full induction of the PtipA promoter under these conditions. Further increases in the thiostrepton concentration did not result in higher VHb production. Without addition of thiostrepton, almost no VHb-specific band was detected in Western blots. This indicates that the PtipA promoter is relatively tightly regulated in S. lividans TK24. Furthermore, the results from the Western blots indicate that the PtipA promoter is approximately five times more active in the induced state than is the PermE'" promoter.
T o verify that the synthesized VHb is biologically active, CO-difference spectrum assays were performed with crude extracts of S. lividans TK24 carrying pETR364 or pETR35.S. CO-difference spectra typical of active VHb were observed for both constructs: these showed a single specific peak at about 4181120 nm after CO pETR419 (Fig. 2) . After conjugation from E. coli S17.1 into Sac. erythraea, thiostrepton-resistant exconjugants were selected. Counterselection against E. coli was done with nalidixic acid (40 pg ml-l). The isolated Sac. erythraea exconjugants showed only very weak and not reproducible VHb activity, as judged by CO-difference spectrum assays. As confirmed by plasmid isolations from exconjugants, the expression plasmids were not stably maintained and underwent recombination in Sac. erythraea (data not shown).
treatment of the soluble fraction, following reduction with sodium hydrosulphite (data not shown).
Although the vhb expression vectors described above worked well in S. liuidans TK24, we were unable to transform Sac. erythraea with these plasmids. Therefore, a set of alternative expression plasmids for VHb production was constructed based on different promoters and transformation procedures.
Construction of a conjugable vhb expression plasmid
Intergeneric conjugation of plasmids from E. coli to Sac. erythraea has been described by Mazodier et al. (1989) and seems in some cases to be even more efficient than transformation (Bierman et al., 1992 (Chater, 1986) Fig. 3 . Construction of pETR432. The PmerR promoter and vhb were amplified by PCR and cloned into the vector plC19H t o give the plasmid pETR407. Primers used in the PCR reactions were 5'-lTGTCGACCCGCGGCGAATGCGCCGG-3' and 5'-lTGAAT-TCCCTITCCACCAGCAGCTA-3' for PmerR, and 5'-lTGAATTCATGlTAG ACCAG CAAACC-3' and 5'-G G ATCCTTAlTCAACCG ClTG AG-C-3' for vhb, respectively. The &31 a t t site was isolated as a Hindlll fragment (carrying the att site and the 5' end of the integrase gene) from pJOE706 (not shown) and after filling in the ends with Klenow polymerase was inserted into the Nruldigested plasmid pETR407 t o give pETR428. For selection the thiostrepton-resistance gene (tsr) from pJOE2139.1 (not shown) was cloned (BgllIIXhol, Klenow) into pETR428 (Pstl, Klenow), resulting in pETR432.
Sac. erythraea produced 3.8-3-9 g erythromycin 1-l. A similar result (3-6 g 1-') was obtained with the recombinant strain Sac. erythraea : : pETR451. Under identical conditions, Sac. erythraea : : pETR432 produced up to 6.3 g erythromycin l-l, a value which was also obtained for other transformants (Fig. 5) . This represents an increase in the product titre of approximately 60 % .
With all strains, the maximum titre was reached at day 8 of the cultivation and then remained constant until the end of the fermentation, at day 9. In contrast to the original strain, erythromycin accumulation in Sac. erythraea : : pETR432 seemed to be faster during the first 3 d of cultivation. After that the erythromycin accumulation rates remained the same in both strains until, at around days 7 and 8, a drastic increase in erythromycin accumulation was observed for the genetically engineered strain, compared to the original Sac. erythraea strain. As calculated from the total protein concentrations, the original Sac. erythraea and the recombinant strain Sac. erythraea : : pETR432 produced similar biomasses during the cultivation (1-6 g 1-1 and 1.4 g 1-' at day 9, respectively).
The chromosoma~ integration and expression of u h~ in cells showing thiostrepton resistance was determined in transformants of both strains was demonstrated by Southern and Western blot analysis (Fig. 4a) and by cultures grown in the absence of thiostrePton* Cells from each sample taken for the erythromycin assays PCR (data not shown). In addition, a DNA fragment was amplified from c~r o m o s o m a~ DNA of sac. erythraea that had been transformed with pETR432 using primers. ~h~ amplified fragment was cloned into p~~1 9~ and sequenced to confirm that it had the correct DNA sequence of uhb.
were Plated onto R.5 agar. Single colonies that emerged were replica-plated onto agar plates containing thiostrepton. The fraction of the colonies that remained thiostrepton resistant after 9 d cultivation in production medium without thiostrepton was greater than 97% (data not shown), demonstrating that the uhb expression cassette was stably integrated into the chromosome of Biological activity of synthesized VHb was demonSac. erythraea. Both plasmids have high copy numbers and can only replicate in Streptomyces spp. However, none of these expression plasmids could be transformed into Sac. erythraea by conventional transformation procedures.
Even electroporation of mycelia or protoplasts did not yield any transformants. This inefficient transformation could be due in part to the small quantity and poor quality of the DNA isolated from S. liuidans. However, transformation of poorly characterized, highly developed, and randomly mutagenized industrial production strains is often difficult, if not impossible, to achieve.
Reports on efficient intergeneric conjugation of plasmids from E. coli into several Streptomyces strains pointed to a reasonable alternative. It has been shown that, besides S. liuidans and Streptomyces coelicolor, Streptomyces pristinaespiralis and Streptomyces uiridochromogenes could be used as recipients in conjugation experiments (Mazodier et al., 1989) . Furthermore, it was reported that plasmids could be conjugated into Streptomyces fradiae, Streptomyces ambofaciens and even into Saccharopolyspora spinosa, strains that are barely transformable by PEG-mediated protoplast transformation (Bierman et al., 1992) . All of these conjugation systems require the origin of transfer (oriT) from RK2 in cis (Guiney & Yakobson, 1983) and transfer functions supplied in trans from the donor strain E. coli S17.1. Therefore, a conjugable uhb expression plasmid was constructed. The resulting plasmid, pETR419, was transformed into E. coli S 17.1 and then conjugated with Sac. erythraea to yield thiostrepton-resistant exconjugants. Although the selected clones seemed to synthesize small amounts of active VHb, it turned out that the expression plasmids were unstable in Sac. erythraea. This instability could be in part a result of homologous recombination between the PermE" fragment of the expression plasmid and the chromosomal ermE region within the erythromycin biosynthesis cluster of this strain.
Thus, it was decided to integrate a uhb expression cassette into the chromosome of Sac. erythraea and to replace PermE" with another constitutive promoter (PmerR) from S. liuidans 1326. This construction was expected to reduce the likelihood of homologous recombination with the erythromycin biosynthetic genes.
As the target for site-specific integration, the Streptomyces phage 4C31 attachment site was chosen. This had previously been used for the successful integration of plasmids into the chromosomes of S. liuidans, S. fradiae and S. ambofaciens (Bierman et al., 1992) .
The resulting uhb-expressing construct, pETR432, which contained the PmerR-vh6 expression cassette, the thiostrepton resistance gene (tsr) and a fragment carrying the 4C3 1 attachment site, was successfully transformed into Sac. erythraea. The chromosomal Improved erythromycin production in Sac. erythraea ~~ integration of vhb was demonstrated by Southern blot analysis and PCR amplification of vhb from chromosomal DNA extracted from Sac. erythraea : : pETR432. All tested transformants showed the same restriction pattern in Southern blots. This indicates that integration of the plasmid had occurred at a specific site, which was probably the 4C31 or similar phage attachment site of the Sac. erythraea chromosome. Integration at this site did not have negative effects on the erythromycin production or growth of the recombinant strain. Furthermore, the integration was shown to be stable for at least the duration of a single erythromycin production batch process (9 d ) in the absence of selection pressure with thiostrepton.
CO-difference spectrum assays confirmed the synthesis of active VHb. A typical VHb CO-difference spectrum with an absorption maximum at 420 nm was observed in S. lividans. With crude extracts of Sac. erythraea : : pETR432, two absorption maxima were detected : one at 450 nm and one at 418 nm. Whilst the peak at 418 nm was clearly related to vhb expression, the peak at 450 nm was probably generated by cytochrome P-450 monooxygenases in Sac. erythraea . The same 450 nm peak was also observed in CO-difference spectra of Sac. erythraea not expressing vhb. The absorption maximum at 418 nm demonstrated that active VHb was synthesized.
The most important outcome of this study was that erythromycin production in the genetically modified industrial production strain was not adversely affected.
By contrast, shake-flask cultivations with Sac. erythraea : : pETR432 reproducibly showed a 60 YO higher erythromycin titre compared to the original, VHb-negative strain. The increase was mostly due to the higher erythromycin production rate during the first 3 d of cultivation and an additional strong increase after day 7. The increase in erythromycin accumulation in the recombinant strain is not due to a higher biomass production since the biomass yields of both strains were similar throughout the cultivation. Furthermore, no significant difference in mycelial fragmentation was observed between the two strains (decreased mycelial fragmentation may lead to increased productivity : Bushell et al., 1997) . Therefore we assume that the improved erythromycin production in the vhb-expressing strain is a consequence of an increased erythromycin biosynthetic flux. This might be the result of an increased activity of an oxygen-dependent step in erythromycin synthesis, most likely the C-6 hydroxylation of 6-deoxyerythronolide B by EryF or/and the final hydroxylation step by EryK (Stassi et al., 1993) .
We have described here for the first time successful genetic manipulation of an industrial erythromycinproducing strain of Sac. erythraea. The preliminary erythromycin production titres from shake flasks probably do not reflect the production potential of the new vhb-expressing strain since the culture conditions have not been optimized for this strain.
